secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001753926-26-000094
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Pelthos Therapeutics revises non-employee director compensation, increases Chairman cash retainer to $60k
--------------------------------------------------------------------------------

- Non-Executive Chairman annual cash retainer increased from $50k to $60k, effective January 1, 2026.
- New annual cash retainers for committee service: Audit Chair $19k, Compensation Chair $15k, Nominating Chair $12k.
- Board member annual cash retainer unchanged at $40k; no annual equity grants to non-employee directors.
- Changes based on compensation committee assessment to align with peer group practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/0001753926-26-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/g085077_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer